$1.14 Trillion is the total value of WestEnd Advisors, LLC's 37 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
PYPL | Sell | PayPal Holdings, Inc. | $56,874,455,000 | -11.0% | 888,247 | -25.4% | 4.99% | -8.7% |
GILD | Sell | Gilead Sciences, Inc. | $56,832,532,000 | +6.3% | 701,463 | -7.1% | 4.99% | +9.0% |
BMY | Sell | Bristol-Myers Squibb | $56,114,848,000 | +8.7% | 880,371 | -5.0% | 4.92% | +11.5% |
BIIB | Sell | Biogen, Inc. | $56,066,641,000 | +9.0% | 179,058 | -5.6% | 4.92% | +11.8% |
MA | Sell | Mastercard Inc. | $55,933,838,000 | -0.1% | 396,132 | -14.1% | 4.91% | +2.5% |
CELG | Sell | Celgene Corp. | $54,185,983,000 | +0.7% | 371,595 | -10.3% | 4.76% | +3.3% |
MSFT | Sell | Microsoft Corp | $52,077,598,000 | -5.5% | 699,122 | -12.6% | 4.57% | -3.1% |
AAPL | Sell | Apple, Inc. | $51,960,633,000 | -2.4% | 337,144 | -8.8% | 4.56% | +0.1% |
UNH | Sell | UnitedHealth Group, Inc. | $51,270,788,000 | -10.0% | 261,786 | -14.8% | 4.50% | -7.7% |
GS | Sell | Goldman Sachs Group | $51,261,977,000 | -2.4% | 216,122 | -8.7% | 4.50% | +0.2% |
JPM | Sell | JPMorgan Chase & Co. | $50,725,743,000 | -4.6% | 531,104 | -8.7% | 4.45% | -2.1% |
GOOGL | Sell | Alphabet Inc. Class A | $50,695,758,000 | -8.9% | 52,064 | -13.0% | 4.45% | -6.5% |
SBUX | Sell | Starbucks Corp | $45,807,379,000 | -14.9% | 852,865 | -7.7% | 4.02% | -12.7% |
MDT | Sell | Medtronic Inc. | $44,377,506,000 | -21.2% | 570,625 | -10.0% | 3.89% | -19.1% |
AGN | Sell | Allergan plc | $41,997,329,000 | -21.1% | 204,915 | -6.4% | 3.68% | -19.1% |
XLK | Sell | Technology Select Sector SPDR Fund | $18,082,472,000 | +7.3% | 305,964 | -0.6% | 1.59% | +10.1% |
SPSB | Sell | SPDR Barclays Short Term | $5,911,366,000 | -25.1% | 192,741 | -25.2% | 0.52% | -23.1% |
IEUR | Sell | iShares Core MSCI Europe ETF | $5,173,973,000 | -18.8% | 104,146 | -23.4% | 0.45% | -16.7% |
ADBE | Sell | ADOBE SYSTEMS | $22,526,000 | -100.0% | 151 | -100.0% | 0.00% | -100.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-03
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VANGUARD INTL EQUITY INDEX F A | 38 | Q3 2023 | 9.0% |
SELECT SECTOR SPDR TR SBI HEAL | 38 | Q3 2023 | 13.8% |
SELECT SECTOR SPDR TR SBI CONS | 38 | Q3 2023 | 6.5% |
SELECT SECTOR SPDR TR SBI CONS | 38 | Q3 2023 | 6.7% |
APPLE INC COM | 36 | Q3 2023 | 5.2% |
TJX COS INC NEW | 36 | Q3 2023 | 5.7% |
ISHARES TR RUSSELL 3000 | 36 | Q4 2022 | 0.0% |
DISNEY WALT CO | 33 | Q3 2023 | 5.4% |
iShares iBoxx $ Invest. Grade Corp Bd ETF | 33 | Q4 2021 | 2.6% |
SPDR TR UNIT SER 1 | 33 | Q3 2023 | 3.5% |
View WestEnd Advisors, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-07 |
13F-HR | 2024-01-18 |
13F-HR | 2023-10-19 |
13F-HR | 2023-07-21 |
13F-HR | 2023-04-28 |
13F-HR | 2023-01-31 |
13F-HR | 2022-10-27 |
13F-HR | 2022-07-28 |
13F-HR | 2022-04-26 |
13F-HR | 2022-01-14 |
View WestEnd Advisors, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.